510(k) device
iTEAR100 Neurostimulator
Olympic Ophthalmics · Electromechanical Tear Stimulator (QKV, Class II) · First FDA decision Mar 16, 2022, newest Mar 16, 2022Dry eye
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "iTEAR100"
MAUDE reports
0
Brand "iTEAR100", since 2015
PubMed studies
1
Mentioning "iTEAR100"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing iTEAR100 Neurostimulator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- iTEAR100 Neurostimulator510(k)
K213623 · Decided Mar 16, 2022 · 120 days after receipt
Device type: Electromechanical Tear Stimulator (QKV) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "iTEAR100", any status and sponsor, newest update first.
- iTear Single-center, Open-label, Single-arm StudyStatus unknown
The University of Hong KongAcademic, hospital or other
NCT06525961 · 30 participants (planned) · Start Aug 2024 · Primary completion Aug 2025
Device: iTEAR100 Neurostimulator · For: Dry Eye Disease; Dry Eye Syndromes; Dry Eye and 1 more
Sites: Hong Kong, Hong Kong
- A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and NeurostimulationStatus unknown
Olympic Ophthalmics, Inc.Not on our public-company list
NCT06235450 · 200 participants (planned) · Start Jan 19, 2024 · Primary completion Dec 31, 2025
Device: iLIDS100 · For: MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome
Sites: Issaquah, Washington
Olympic Ophthalmics, Inc.Not on our public-company list
NCT05304650 · 100 participants (planned) · Start Mar 1, 2022 · Primary completion Apr 30, 2022
Device: iTEAR100 · For: Dry Eye Syndromes
Sites: Issaquah, Washington
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "iTEAR100", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QKV
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "iTEAR100"[tiab]. The summary above synthesizes these.
- Focused Narrative Review: Non-Pharmacological, Noninvasive Neurostimulation or Neuromodulation Treatment of Ocular Neuropathic Pain.
Tong L, Liu YC · Clin Ophthalmol · 2026Review
Other devices of this type
Also filed under product code QKV.
- iTEAR NeurostimulatorOlympic Ophthalmics, Inc. · De Novo 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.